GM Financial Consumer files Form 10-D for period ended Sept. 30
GM Financial Consumer filed a Form 10-D for the period ended Sept. 30. The filing date is shown as October 27, but the year is truncated in the source.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
GM Financial Consumer Files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D for the period ended September 30.
GM Financial Consumer files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D covering the period ended September 30.
GM Financial Consumer files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D covering the period ended September 30.
GM Financial Consumer Files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D for the period ending September 30.
GM Financial Consumer Files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D for the period ending September 30.
GM Financial Consumer files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D for the period ending September 30.
GM Financial Consumer Files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D for the period ended September 30.
GM Financial Consumer files Form 10-D for September 30
A Form 10-D for GM Financial Consumer covering September 30 was filed on October 27.
GM Financial Consumer files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D covering the period ending September 30.
GM Financial Consumer files Form 10-D for September 30
GM Financial Consumer filed a Form 10-D for the period ended September 30. The filing date is shown as October 27, but the year is truncated.
Integra LifeSciences files 8-K on debt refinancing
Integra LifeSciences filed an 8-K reporting the pricing of $450 million of 9.500% senior secured notes due 2033 in a private placement. The company said the refinancing plan is expected to lift its effective interest rate near the high end of its previously communicated 100-200 basis point range.
Aldel Financial II files 8-K on agreement amendment
Aldel Financial II said it filed an 8-K with the SEC covering an amendment to its investment management trust agreement. The amendment was dated Oct. 7, 2026, and the filing was dated Oct. 9, 2026.
Sunshine Biopharma files 8-K on placement agreement
Sunshine Biopharma said it entered into a placement agent agreement with Aegis Capital Corp. for a best efforts public offering that closed Oct. 9. The company said gross proceeds were about $6 million before fees and expenses.
Flyte Aviation files 8-K on $2.05 million preferred sale
Flyte Aviation said existing investors agreed to buy 2,050 shares of Series C-4 convertible preferred stock for gross proceeds of $2.05 million. The closing is expected on or about October 13, subject to customary closing conditions.
Serina Therapeutics files 8-K on certificate elimination
Serina Therapeutics filed an 8-K describing a Delaware certificate of elimination that removes its Series A Convertible Preferred Stock designation. The company said no Series A Preferred Stock shares are outstanding because all issued shares were converted into common stock.
Arrive AI files 8-K on $250,000 private placement
Arrive AI said it entered a securities purchase agreement for a $250,000 private placement with an accredited investor. The company plans to use the proceeds for general working capital and must file a resale registration statement within 20 days of closing.
Vistagen files 8-K on executive severance plan
Vistagen Therapeutics filed an 8-K describing amendments to its Change in Control Executive Severance Plan. The changes expand circumstances for severance benefits and revise the plan’s eligibility and change-in-control definitions.
Live Nation files 8-K on new senior notes offering
Live Nation said it priced $730 million of senior notes due 2032 and €600 million of senior notes due 2032 in a private offering. The company plans to use the proceeds to redeem its 6.500% senior secured notes due 2027 and for general corporate purposes.
Impact BioMedical files 8-K on reverse stock split
Impact BioMedical said it completed a 1-for-12.62 reverse stock split of its common stock on Sept. 23 and began trading on a split-adjusted basis the same day. The filing said the split reduced its issued and outstanding common shares to about 8.6 million.
Sculptor Diversified Real Estate files 8-K on equity sales
Sculptor Diversified Real Estate Income Trust said it filed an 8-K covering unregistered equity sales. The filing lists shares issued on October 1 and September 11, including sales under distribution reinvestment plans and payments of accrued management fees.
Selectis Health files 8-K on board, officer changes
Selectis Health said in an SEC filing that several directors and its interim CFO ceased serving at the effective time of the merger. It also said Abraham Schwartz and Zalman Schapiro became the company’s directors and officers.
Selectis Health files 8-K on change in control
Selectis Health said in an SEC filing that it completed a merger that left the company a wholly owned subsidiary of Purchaser and an indirect wholly owned subsidiary of Parent.
Selectis Health files 8-K on credit agreement
Selectis Health filed an 8-K saying it became a borrower under a credit agreement tied to its merger. The term loans bear a fixed 5.0% annual rate and mature on Aug. 28, 2031.
Xcel Energy unit files Minnesota rate stability plan
Northern States Power Company Minnesota filed an Electric Customer Rate Stability Plan with the Minnesota Public Utilities Commission as an alternative to a planned rate case filing. The proposal calls for a customer base rate freeze in 2027 and 2028 and seeks a decision by January 2027.
King Family Trust files Form 144 for 50,000 Chime shares
King Family Trust filed a Form 144 with the SEC indicating an intention to sell 50,000 Chime Financial Inc shares (CHYM), registered on 10/9/2026, with an approximate sale date of 10/9/2026. The filing permits sales within 90 days after being mailed to the SEC.
Vaxcyte Files 8K - Entry Into Definitive Agreement >PCVX
Vaxcyte Inc. (PCVX) filed a Form 8K - Entry Into a Definitive Agreement - with the U.S Securities and Exchange Commission on October 09, 2026. On October 9, 2026, Vaxcyte, Inc. ("Vaxcyte") consummated the sale and issuance of $575,000,000 aggregate principal amount of its 1.50% Convertible Senior Notes due 2032 (the "N
T Stamp files 8-K on equity distribution agreement
T Stamp said it entered into an equity distribution agreement with Maxim Group LLC under which it may sell shares of common stock from time to time. The ATM prospectus covers up to $5,323,474 of stock sales.
Fluence Energy files 8-K on executive separation
Fluence Energy said former Senior Vice President and Chief Product Officer Peter Williams entered a separation agreement and release of claims. The filing says he will receive cash, accelerated vesting of RSUs and PSUs, and COBRA reimbursement if he meets the agreement conditions.
Evernorth Holdings files 8-K on company status change
Evernorth Holdings said it filed an 8-K with the SEC and that, as a result of the business combination, Pubco ceased to be a shell company. The filing said the material terms are described in the report’s introductory note and Item 2.01.